Regimen method of mediating neuronal damage using nitroglycerine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5455279
SERIAL NO

08025028

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed is a method for decreasing NMDA receptor-mediated neuronal damage in a mammal by administering to the mammal a nitroso-compound that generates nitric-oxide or related redox species, in a concentration effective to effect neuroprotection. Also disclosed is a method for decreasing NMDA receptor-mediated neuronal damage in a mammal by administering to the mammal a nitroso-compound that generates nitric oxide (or a related redox species such as NO.sup.31 or NO.sup.+ equivalent), or a physiologically concentration effective to cause such neuroprotection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHILDREN'S MEDICAL CENTER CORPORATION THE55 SHATTUCK STREET BOSTON MA 02115

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lipton, Stuart A Newton, MA 47 676

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation